Diagnosis and treatment of junctional cancer from a global perspective-Reference-Cited by-同舟云学术

Diagnosis and treatment of junctional cancer from a global perspective

Published:2024-03-15 Issue:7 Volume:37 Page:
ISSN:1120-8694
Container-title:Diseases of the Esophagus
language:en
Short-container-title:

Author:

Wijnhoven Bas P L¹,Griffiths Ewen A²^ORCID

Affiliation:

1. Erasmus University Medical Cancer, Department of Surgery and Erasmus MC Cancer Institute , Wijnhoven, PO Box 2040, Rotterdam, 3000 CA , the Netherlands

2. Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital, University Hospitals Birmingam NHS Foundation Trust , Edgbaston, Birmingham, B15 2TH , UK

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/dote/article-pdf/37/7/doae017/58403230/doae017.pdf

Reference9 articles.

1. Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction;Grotenhuis;World J Surg,2013

2. Esophagectomy or Total gastrectomy for Siewert 2 gastroesophageal junction (GEJ) adenocarcinoma? A registry-based analysis;Kamarajah;Ann Surg Oncol,2021

3. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II;Leers;BMC Cancer,2020

4. Clinical practice guidelines for esophagogastric junction cancer: upper GI oncology summit 2023;Kitagawa;Gastric Cancer,2024

5. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI;Al-Batran;BMC Cancer,2017